Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of RFUS-144 Injection for postoperative analgesia
CTR20241142Phase 2Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RFUS-144 in postoperative pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Apr 2024; status: completed.
02
Drugs
RFUS-144
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20241142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241142.